Scientific Management

Vladimir Khazak Igor Astsaturov Eric Golemis Emily S. Arcamone


CSO, chief scientific officer

Dr. Vladimir Khazak is an experienced biologist with more than 20 years of working in multiple biopharmaceutical companies. He is the co-founder and Chief Scientific Officer of NexusPharma, heading biology research and development. He received an M.S. and Ph.D. from Chemical-Technical University, Moscow Institute for Genetics and Selection of Microorganisms, in Moscow, Russia. He completed his postdoctoral research at Fox Chase Cancer Center in Philadelphia, PA in the relationship between basic transcriptional apparatus and stress. Particular areas of expertise include genetics and molecular oncology with a particular emphasis on protein-protein interaction, gene regulation/expression and signal transduction.


FCCC, Philadelphia

Dr. Astsaturov is an MD, Ph.D. scientific advisory board member of NexusPharma, as well as a physician at FCCC. He is a Co-Director of Marvin & Concetta Greenberg Pancreatic Cancer Institute. His clinical expertise is in gastrointestinal cancers, including pancreatic, colorectal, and liver cancer.


FCCC, Philadelphia

Dr. Erica Golemis is a scientific advisory board member of NexusPharma. Erica is Deputy Chief Scientific Officer planning the future of cancer research at Fox Chase Cancer Center.

Emily S. Arcamone

Business Development Account Manager, External Alliance Project Coordinator

Emily joined the GGG team in 2013. As Business Development Account Manager and External Alliance Project Coordinator, she develops proposals and assist with the execution of contracts and service agreements. To accomplish that she works with scientific project leaders and project management staff to establish and initiate new study proposals. She interacts with cross-functional scientific directors through the strategic planning and delivery of the development program, proactively identifying and managing issues in order to ensure satisfactory turn-around-time to all incoming projects. Emily has over 20 years of experience working in the biotechnology field, including over 15 years in a management role. She joined Invivotek’s management team as a Resource Coordination Manager from Taconic Biosciences, where she had a similar title. Emily has extensive experience in the planning, scheduling, and allocation of resources to maximize the efficiency of the team including in vivo and in vitro Research Associates Emily received her B.S. in Animal Sciences from Rutgers University


We are supported by a highly regarded international network of scientific collaborators, development experts, and other expert advisors, enabling a “virtual” development framework with:

  • Specific biological expertise at universities and institutions such as the University of North Carolina at Chapel Hill, the University of California at Los Angeles, the University of Pennsylvania, as well as the University of Munich, Germany

  • Collaborations on animal models and further drug development through the National Cancer Institute

  • Animal pharmacokinetic and pharmacodynamics studies, and custom medicinal chemistry, through contract research organizations (CROs)